These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5754252)

  • 21. [Preliminary observations with ultra-delayed elimination sulfonamide in the treatment of leprosy].
    Pereira Junior AC
    An Bras Dermatol; 1967; 42(1):35-45. PubMed ID: 5633700
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of Hansen's disease with delayed-action sulfamides].
    Languillon J
    Dermatol Int; 1968; 7(2):84-9. PubMed ID: 5741774
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aspects of the treatment of mycoses].
    Magalhães MJ
    J Med (Oporto); 1965 Dec; 58(194):885-94. PubMed ID: 5215329
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 25. [Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone].
    Merklen FP; Cottenot F; Pennec J; Vernant JC; Buzacoux J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):461-2. PubMed ID: 5150887
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 27. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current status of the medical treatment of Hansen's disease].
    Coudert J; Lu HT
    J Med Lyon; 1972 Sep; 53(232):1047-54. PubMed ID: 4638074
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of leprosy with long-acting sulfonamides].
    Languillon J
    Sem Hop; 1965 Dec; 41(53):3131-8. PubMed ID: 4285224
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of leprosy].
    Ilardi I; Mazzacurati G
    Clin Ter; 1969 Feb; 48(3):265-88. PubMed ID: 4929555
    [No Abstract]   [Full Text] [Related]  

  • 31. [Re-evaluation of anti-Hansenian chemotherapy by long-term study and by experimental and pharmacokinetic criteria].
    Carayon A
    Acta Leprol; 1980; (79):55-65. PubMed ID: 6794334
    [No Abstract]   [Full Text] [Related]  

  • 32. Delay in presentation and start of treatment in leprosy patients: a case-control study of disabled and non-disabled patients in three different settings in Ethiopia.
    Bekri W; Gebre S; Mengiste A; Saunderson PR; Zewge S
    Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):1-9. PubMed ID: 9614833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The promin treatment of leprosy. A progress report.
    Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
    Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
    [No Abstract]   [Full Text] [Related]  

  • 34. The leprosy eradication-project of Malta.
    Agius-Ferrante A; Depasquale G; Bonnici E; Paris C; Grima W
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:49-52. PubMed ID: 4780897
    [No Abstract]   [Full Text] [Related]  

  • 35. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones.
    Bechelli LM; Dominguez VM
    Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809
    [No Abstract]   [Full Text] [Related]  

  • 36. [Late evolutive recurrences of formerly treated leprosy].
    Merklen FP; Cottenot F; Pennec J; Blanchet P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):459-61. PubMed ID: 5170176
    [No Abstract]   [Full Text] [Related]  

  • 37. Reappraisal of functional and structural changes in liver in leprosy.
    Gupta MC; Kumar S; Tyagi SP
    J Assoc Physicians India; 1974 Jan; 22(1):13-8. PubMed ID: 4844724
    [No Abstract]   [Full Text] [Related]  

  • 38. Histoid (high-resistance) lepromatous leprosy.
    Price EW; Fitzherbert M
    Int J Lepr Other Mycobact Dis; 1966; 34(4):367-74. PubMed ID: 6006068
    [No Abstract]   [Full Text] [Related]  

  • 39. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 40. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.